anti-alphaVbeta3 integrin-kinesin spindle protein inhibitor drug conjugate (Vincerx Pharma)

N/A

Report date: 2025/06/11 10:31:02
NME

Base Information

Drug Nameanti-alphaVbeta3 integrin-kinesin spindle protein inhibitor drug conjugate (Vincerx Pharma)
Drug Alias NamealphaVbeta3-targeting small molecule drug conjugate (Vincerx Pharma)
ClassificationSmall molecules
Mechanisms of ActionKinesin-like protein 1 inhibitorsIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3Kinesin-like protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVincerx Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesVincerx Pharma Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A